MoonLake Immunotherapeutics (MLTX) Stock Price & Analysis
MLTX$12.63+0.32 +2.60%
$1.07B
Market Cap
-3.08
P/E
5.28
Forward P/E
71
Score
MoonLake Immunotherapeutics (MLTX) Stock Price & Analysis
MLTX price $12.63 +0.32 +2.60%
- Ticker
- MLTX
- Price
- $12.63
- Change
- +0.32 +2.60%
- Market cap ?
- $1.07B
- P/E ?
- -3.08
- Forward P/E ?
- 5.28
- Dividend yield ?
- 0.00%
- Beta ?
- 1.08
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 71
- Value
- 60
- Quality
- 52
- Growth
- 100
Stocklytics score rationale: value 60, quality 52, growth 100.
Financials
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 |
MoonLake Immunotherapeutics operates as a clinical-stage biopharmaceutical company, concentrating its efforts on discovering and developing novel therapies. The company's primary focus is the advancement of Sonelokimab, an innovative, investigational Nanobody-based treatment engineered to target inflammatory conditions. Currently, Sonelokimab is undergoing mid-stage (Phase II) clinical trials for a range of…
Insights · Dividends · Forecast · Financials · Learn